State Street
NBP

State Street’s NovaBridge Biosciences American Depositary Shares NBP Stock Holding History

State Street’s Portfolio NBP Stock Details NBP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$703K Sell
360,376
-9,731
-3% -$19.8K ﹤0.01% 3513
2026
Q1 		$910K Buy
370,107
+10,229
+3% +$34.2K ﹤0.01% 3509
2025
Q4 		$1.43M Buy
359,878
+22,478
+7% +$99.5K ﹤0.01% 3438
2025
Q3 		$1.28M Buy
+337,400
New +$1.15M ﹤0.01% 3455
2024
Q3 		– Sell
-102,961
Closed -$172K – 4316
2024
Q2 		$172K Sell
102,961
-7,412
-7% -$13.2K ﹤0.01% 3863
2024
Q1 		$205K Buy
110,373
+8,674
+9% +$16K ﹤0.01% 3870
2023
Q4 		$193K Buy
101,699
+2,174
+2% +$3.25K ﹤0.01% 3907
2023
Q3 		$131K Sell
99,525
-407,107
-80% -$894K ﹤0.01% 4042
2023
Q2 		$1.51M Sell
506,632
-13,641
-3% -$43.8K ﹤0.01% 3495
2023
Q1 		$1.8M Buy
520,273
+32,696
+7% +$158K ﹤0.01% 3371
2022
Q4 		$2.04M Buy
487,577
+5,939
+1% +$22.5K ﹤0.01% 3368
2022
Q3 		$1.93M Sell
481,638
-1,166
-0.2% -$8.85K ﹤0.01% 3425
2022
Q2 		$5.46M Sell
482,804
-268,450
-36% -$3.22M ﹤0.01% 3060
2022
Q1 		$12.2M Buy
751,254
+127,890
+21% +$3.28M ﹤0.01% 2715
2021
Q4 		$29.5M Buy
623,364
+76,142
+14% +$4.57M ﹤0.01% 2182
2021
Q3 		$39.7M Buy
547,222
+104,897
+24% +$7.59M ﹤0.01% 1983
2021
Q2 		$37.1M Buy
442,325
+424,738
+2,415% +$28M ﹤0.01% 2068
2021
Q1 		$852K Buy
17,587
+2,295
+15% +$125K ﹤0.01% 3655
2020
Q4 		$721K Buy
+15,292
New +$602K ﹤0.01% 3607

Other funds holding NBP

HA
HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
ACM
AIHC Capital Management Central $104M AUM
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
CS
Candriam SCA Strassen, Luxembourg, Luxembourg $22.2B AUM 58.34% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street's NBP Position: Q2 2026 in Review

State Street reduced its NovaBridge Biosciences American Depositary Shares (NBP) stake by 2.6% in Q2 2026, selling an estimated $19.8K and leaving 360,376 shares worth $703K. The position accounts for ﹤0.01% of the portfolio, ranked #3513.

State Street first reported a position in NBP in Q4 2020 and has held it in 19 quarters since. The position peaked at $39.7M in Q3 2021. 49 funds tracked by Wall St. Rank hold NBP as of Q2 2026.

  • State Street held 360,376 shares of NovaBridge Biosciences American Depositary Shares worth $703K as of Q2 2026.
  • State Street sold 9,731 NovaBridge Biosciences American Depositary Shares shares in Q2 2026, an estimated $19.8K.
  • NovaBridge Biosciences American Depositary Shares made up ﹤0.01% of State Street's portfolio in Q2 2026, its #3513 holding.
  • State Street first reported a position in NovaBridge Biosciences American Depositary Shares in Q4 2020 and has held it in 19 quarters since.
  • State Street's NovaBridge Biosciences American Depositary Shares position peaked at $39.7M in Q3 2021.
  • 49 funds tracked by Wall St. Rank held NovaBridge Biosciences American Depositary Shares as of Q2 2026.

Based on State Street's 13F filing for Q2 2026, filed 7 Aug 2026.